MedTrace Logo

Study of Utilization Patterns of Dimethyl Fumarate in Germany

NCT02969304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 930

Last updated 2017-07-19

No results posted yet for this study

Summary

The primary objective of this study is to estimate the proportion of DMF use that is prescribed "on-label" versus "off-label". The secondary objectives are: To describe the demographic characteristics and medical history of DMF users; To describe prescription drug history and concomitant medication use of DMF users; To describe the duration of therapy in participants newly initiating DMF treatment; To describe the medical specialties of DMF prescribers.

Conditions

Interventions

DRUG

dimethyl fumarate

Off-Label Use: All participants \<18 years of age and participants without an MS diagnosis who are prescribed dimethyl fumarate On-Label Use: All participants \>18 years of age with an MS diagnosis who are prescribed dimethyl fumarate

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Biogen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-30
Primary Completion
2017-03-02
Completion
2017-03-02

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969304 on ClinicalTrials.gov